Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Okyo Pharma Ltd (EMMLF)

Okyo Pharma Ltd (EMMLF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0137 -0.0066 (-32.51%) 05/12/23 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0137 unch (unch) -
Quote Overview for Fri, May 12th, 2023
Day Low
0.0137
Day High
0.0369
Open 0.0369
Previous Close 0.0203 0.0203
Volume 10,100 10,100
Avg Vol N/A N/A
Stochastic %K N/A N/A
Weighted Alpha N/A N/A
5-Day Change -0.0463 (-77.17%) -0.0463 (-77.17%)
52-Week Range 0.0137 - 0.0835 0.0137 - 0.0835
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.39
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0137 unch
on 05/12/23
Period Open: 0.0203
0.0369 -62.87%
on 05/12/23
N/A (-32.51%)
since 03/17/23
3-Month
0.0137 unch
on 05/12/23
Period Open: 0.0201
0.0835 -83.59%
on 02/17/23
-0.0064 (-31.84%)
since 01/04/23

Most Recent Stories

More News
OKYO Pharma Limited - PDMR Dealing

LONDON and BOSTON, May 20, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a life sciences company focused on the discovery and...

OKYO : 1.3500 (+7.14%)
EMMLF : 0.0137 (-32.51%)
OKYO.LN : 1.400 (-24.32%)
OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing

LONDON, May 19, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a life sciences company focused...

OKYO : 1.3500 (+7.14%)
EMMLF : 0.0137 (-32.51%)
OKYO.LN : 1.400 (-24.32%)
OKYO Pharma Limited - PDMR Dealing

LONDON and NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a biotechnology company focused on the discovery and...

OKYO : 1.3500 (+7.14%)
EMMLF : 0.0137 (-32.51%)
OKYO.LN : 1.400 (-24.32%)
OKYO Pharma Limited Announces Pricing of Initial Public Offering of ADSs in the U.S. with director participation

LONDON, May 17, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), a life sciences company focused on the...

OKYO.LN : 1.400 (-24.32%)
EMMLF : 0.0137 (-32.51%)
OKYO Pharma Limited Announces Pricing of Public Offering and Nasdaq Listing

LONDON, May 16, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused...

OKYO.LN : 1.400 (-24.32%)
EMMLF : 0.0137 (-32.51%)
OKYO Pharma ("OKYO" or the "Company") - Announces Two Presentations at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

OK-101 ameliorates neuropathic corneal pain in a mouse model of ciliary nerve ligation BAM8-22 peptide analog OK-201 alleviates neuropathic corneal pain...

OKYO.LN : 1.400 (-24.32%)
EMMLF : 0.0137 (-32.51%)
OKYO Pharma Limited ("OKYO" or the "Company") - OKYO publicly files a registration statement with the SEC for a proposed dual-listing on the Nasdaq Capital Market and Offering in the United States

LONDON, March 07, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF) ("OKYO" or the "Company"), a biotechnology company focused on...

OKYO.LN : 1.400 (-24.32%)
EMMLF : 0.0137 (-32.51%)
OKYO Pharma ("OKYO" or the "Company") - announces issuance of U.S. Patent No. 11,254,720 covering OKYO’s dry eye drug candidate OK-101 for use to treat ocular neuropathic pain

LONDON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development...

OKYO.LN : 1.400 (-24.32%)
EMMLF : 0.0137 (-32.51%)
OKYO Pharma Limited ("OKYO" or the "Company") - Conversion of CLNs, cashless exercise of Warrants, and issue of equity

LONDON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development...

OKYO.LN : 1.400 (-24.32%)
EMMLF : 0.0137 (-32.51%)
OKYO Pharma Limited ("OKYO" or the "Company") - Grant of options – Director and PDMR dealings

LONDON, Feb. 01, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development...

OKYO.LN : 1.400 (-24.32%)
EMMLF : 0.0137 (-32.51%)

Key Turning Points

3rd Resistance Point 0.0524
2nd Resistance Point 0.0446
1st Resistance Point 0.0292
Last Price 0.0137
1st Support Level 0.0060
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 0.0835
Fibonacci 61.8% 0.0568
Fibonacci 50% 0.0486
Fibonacci 38.2% 0.0404
Last Price 0.0137
52-Week Low 0.0137

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals